James J. Burns & Company LLC Has $1.72 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

James J. Burns & Company LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 3,409 shares of the healthcare conglomerate’s stock after selling 86 shares during the period. James J. Burns & Company LLC’s holdings in UnitedHealth Group were worth $1,724,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $27,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter worth $30,000. West Financial Advisors LLC bought a new position in UnitedHealth Group in the 3rd quarter valued at $32,000. Quarry LP boosted its holdings in shares of UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 37 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group in the third quarter valued at about $37,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $548.65 on Tuesday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The firm’s fifty day moving average price is $536.17 and its 200-day moving average price is $565.20. The stock has a market cap of $504.91 billion, a P/E ratio of 35.40, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company earned $5.83 EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is presently 54.19%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Truist Financial lowered their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Stephens boosted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Finally, Royal Bank of Canada reduced their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.